Baxter Nicholas W 4
4 · Lexaria Bioscience Corp. · Filed Jun 9, 2021
Insider Transaction Report
Form 4
Baxter Nicholas W
Director
Transactions
- Other
Stock Options
2021-05-07−5,000→ 1,500 totalExercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (5,000 underlying)
Holdings
- 5,000
Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (5,000 underlying) - 6,500
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying) - 11,000
common shares
Footnotes (1)
- [F1]Cancellation of Options